SCHEMBL21928016

SCHEMBL21928016

N#Cc1ccncc1-c1ccccc1-c1ccccc1N1c2ccccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SLC22A12 Q96S37 8/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32
CHRNB2 P17787 2/20 0.31
CHRNA7 P36544 2/20 0.31
CHRNA4 P43681 2/20 0.31
PDE10A Q9Y233 1/20 0.31
HTT P42858 1/20 0.31
SLC22A6 Q4U2R8 1/20 0.30
SLC22A11 Q9NSA0 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21927763 0.99 MEN1 (0.34) ATRMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL21927754 0.89 UCHL1 (0.37) MEN1ALDH1A1CYP1A2CYP3A4THRB
SCHEMBL21927451 0.84 PDE10A (0.36) ALDH1A1CYP1A2CYP3A4SLC22A12PDE10A
SCHEMBL21927228 0.81 ATR (0.36) ATRMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL21928010 0.81 CYP19A1 (0.36) ALDH1A1CYP1A2CYP3A4TDP1NCOA3
SCHEMBL21929610 0.80 ATR (0.37) ATRMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL21396939 0.79 CYP11B2 (0.34) CYP1A2CYP3A4SLC22A12
SCHEMBL21928017 0.78 ALDH1A1 (0.33) ALDH1A1HTT
SCHEMBL20997809 0.78 RPS6KA3 (0.38) CYP1A2CYP3A4SLC22A12CHRNB2CHRNA3
SCHEMBL21927305 0.78 ATR (0.35) ATRMEN1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CCNT1, CCNA1, CCNE2 ATR 1618/4885MEN1 113/4885ALDH1A1 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.